Eubulus

About:

Eubulus is an early-stage company focusing on building a platform technology for therapeutic enhancement.

Top Investors: Innovation and Technology Venture Fund, Viva Biotech, Long Capital, Star Capital, Xiamen Changrong Investment Management

Description:

Eubulus is an early-stage company focusing on building a platform technology for therapeutic enhancement. The company specializes in Proteolysis- targeting chimeras (PROTACSs).

Total Funding Amount:

$10M

Headquarters Location:

Jiaxing, Zhejiang, China

Founded Date:

2018-01-01

Founders:

Number of Employees:

Last Funding Date:

2021-10-14

IPO Status:

Private

Industries: